97精品国产自-97精品国产自产-97精品国产综合久久-97精品久-97精品免费视频-97精品人人

廚房設備網
手機版
首頁> 資訊>政策法規> 正文

(EU) No 2015/1492:就乙酰異戊酰泰樂菌素,修訂法規(EU) No 37/2010附錄

發布時間:2017-05-02 09:35:41   發布人: 互聯網    點擊數:566  

COMMISSION IMPLEMENTING REGULATION (EU) 2015/1492     of 3 September 2015     amending Regulation (EU) No 37/2010 as regards the substance ‘tylvalosin’     (Text with EEA relevance)     THE EUROPEAN COMMISSION,     Having regard to the Treaty on the Functioning of the European Union,     Having regard to Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council (1), and in particular Article 14 in conjunction with Article 17 thereof,     Having regard to the opinion of the European Medicines Agency formulated by the Committee for Medicinal Products for Veterinary Use,     Whereas:     (1)     Article 17 of Regulation (EC) No 470/2009 requires that the maximum residue limit (hereinafter ‘MRL’) for pharmacologically active substances intended for use in the Union in veterinary medicinal products for food-producing animals or in biocidal products used in animal husbandry is established in a regulation.     (2)     Table 1 of the Annex to Commission Regulation (EU) No 37/2010 (2) sets out the pharmacologically active substances and their classification regarding MRLs in foodstuffs of animal origin.     (3)     Tylvalosin is currently included in that table as an allowed substance, for porcine and poultry species, applicable to muscle, skin and fat, liver and kidney in porcine species and to skin and fat and liver in poultry species, excluding animals producing eggs for human consumption.     (4)     An application for the extension of the existing entry for tylvalosin to chicken eggs has been submitted to the European Medicines Agency (hereinafter ‘EMA’).     (5)     The EMA, based on the opinion of the Committee for Medicinal Products for Veterinary Use has recommended the establishment of a MRL for chicken eggs.     (6)     According to Article 5 of Regulation (EC) No 470/2009 the EMA is to consider using MRLs established for a pharmacologically active substance in a particular foodstuff for another foodstuff derived from the same species, or MRLs established for a pharmacologically active substance in one or more species for other species.     (7)     The EMA has considered that the extrapolation of the MRLs for tylvalosin from chicken eggs to eggs of other poultry species is appropriate.     (8)     Regulation (EU) No 37/2010 should therefore be amended accordingly.     (9)     It is appropriate to grant the stakeholders concerned a reasonable period of time to take measures that may be required to comply with the new MRL.     (10)     The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,     HAS ADOPTED THIS REGULATION:     Article 1     The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.     Article 2     This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.     It shall apply from 3 November 2015.     This Regulation shall be binding in its entirety and directly applicable in all Member States.     Done at Brussels, 3 September 2015.     For the Commission     The President     Jean-Claude JUNCKER     (1)  OJ L 152, 16.6.2009, p. 11.     (2)  Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin (OJ L 15, 20.1.2010, p. 1).     ANNEX     In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘tylvalosin‘ is replaced by the following:
   

harmacologically active substance

Marker residue

Animal species

MRL

Target tissues

Other provisions (according to Article 14(7) of Regulation (EC) No 470/2009)

Therapeutic classification

‘Tylvalosin

Tylvalosin

orcine

50 μg/kg

50 μg/kg

50 μg/kg

50 μg/kg

Muscle

kin and fat

Liver

Kidney

O ENTRY

Anti-infectious agents/Antibiotics’

oultry

200 μg/kg

Eggs

um of Tylvalosin and 3-0-acetyltylosin

oultry

50 μg/kg

50 μg/kg

kin and fat

Liver

免責聲明:本網站所收集的部分公開資料來源于互聯網,轉載的目的在于傳遞更多信息及用于網絡分享,并不代表本站贊同其觀點和對 其真實性負責,也不構成任何其他建議。如果您發現網站上有侵犯您的知識產權的作品,請與我們取得聯系,我們會及時修改或刪除。

同類資訊

推薦資訊 更多
點擊排行

版權所有:廚聯科技 (c)2008-2022 CFSBCN All Rights Reserved

客戶服務郵箱:350319542@cfsbcn.com 郵編:610000 蜀ICP備14006818號-4 聯系電話:13880215230

成都地址:成都高新區府城大道西段399天府新谷10號樓17F

主站蜘蛛池模板: 精品一区二区三区视频在线观看 | tv香蕉人人网站 | 国产日韩欧美一区二区三区视频 | 国产伦精品一区二区三区免费观看 | 国产熟女福利 | 2024国产精品自在线拍 | 紧身裙女教师波多野结衣 | 日日碰狠狠躁久久躁综合网 | 成人欧美手机在线观看 | 久久这里只有精品免费播放 | 国产午夜激无码毛片久久hd | 99久久精品免费看国产99 | 国产毛片欧美毛片久久久 | 涩涩琪琪丁香久久综合 | 国内自拍小视频 | 日本一道在线播放高清 | 天天综合永久免费视频 | 国产大尺度福利小视频在线观看 | 国产高清国内精 | 日本高清视频一区二区 | 精品一区二区三区免费毛片 | 亚洲另类av图片在线观看 | 国产丝袜脚脚在线视频 | 亚洲精品亚洲人成在线观看麻豆 | 91热国内精品永久免费观看 | 国产成人一区二区三区 | 国产成a人片在线观看网站 国产成a人亚 | 国产午夜精品一本在线观看 | 国产av一区二区三区蜜芽 | 日韩aⅴ精品一区二区视频 日韩aⅴ人妻无码 | 国产一区二区激情戏 | 亚洲视频一区在线 | 99久久精品国产精品亚洲 | 国产一区二区高清无码 | 国产精品国产三级国av在线观看 | 亚洲国产精品久久久久久网站 | 国产精品视频第一区二区三区 | 国产成人无码综合亚洲日韩榴莲 | 国产亚洲精品久久综合阿香 | 欧美丰满美乳xx高潮www | 久久久久亚洲av成人网人人 |